Skip to Content

Rule

Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of a New Animal Drug Applications; Phenylbutazone; Pyrantel; Tylosin

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations by removing those portions that reflect approval of eight new animal drug applications (NADAs). In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of these NADAs.

DATES:

This rule is effective March 14, 2011.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, e-mail: john.bartkowiak@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The sponsors have requested that FDA withdraw approval of the three NADAs listed in table 1 of this document because the products are no longer manufactured or marketed:

Table 1—Voluntary Requests for Withdrawal of Approval of Three NADAs

SponsorNADA No. product (established name of drug)21 CFR section affected (sponsor drug labeler code)
First Priority, Inc., 1590 Todd Farm Dr., Elgin, IL 60123NADA 48-647; Phenylbutazone Boluses (phenylbutazone)§ 520.1720a (058829).
Yoder Feed, Division of Yoder, Inc., Kalona, IA 52247NADA 96-161; Hy-Con TYLAN Premix (tylosin phosphate)§ 558.625 (035369).
Triple “F”, Inc., 10104 Douglas Ave., Des Moines, IA 50322NADA 119-062; Cadco-BN-10 BANMINTH Premix (pyrantel tartrate)§ 558.485 (011490).

Truow Nutrition, Inc., 1590 Todd Farm Dr., Elgin, IL 60123 (Truow) has informed FDA that it is the owner of five feed premix NADAs previously owned by milling companies which it has purchased. NADA 100-352 was owned by NutriBasics Co., last doing business at P.O. Box 1014, Wilmar, MN 56201. NADA 107-002 and NADA 123-000 were owned by Seeco, Inc., also last doing business at P.O. Box 1014, Wilmar, MN 56201. NADA 133-833 and NADA 135-243 were owned by Southern Micro-Blenders, Inc., last doing business at 3801 N. Hawthorne St., Chattanooga, TN 37406. Truow has requested that FDA withdraw approval of the five NADAs in table 2 of this document because they are no longer manufactured or marketed:Start Printed Page 11331

Table 2—Voluntary Requests for Withdrawal of Approval of Five NADAs by Truow Nutrition, Inc.

Previous sponsorNADA No. product (established name of drug)21 CFR section affected (sponsor drug labeler code)
NutriBasics Co., P.O. Box 1014, Wilmar, MN 56201NADA 100-352; Seeco T-10 Premix (tylosin phosphate)§ 558.625 (053740).
Seeco, Inc., P.O. Box 1014, Wilmar, MN 56201NADA 107-002; Seeco TYLAN-Sulfa 10 Premix (tylosin phosphate and sulfamethazine)Not codified.
Seeco, Inc., P.O. Box 1014, Wilmar, MN 56201NADA 123-000; Super Swine Wormer B-9 BANMINTH(pyrantel tartrate)§ 558.485 (011749).
Southern Micro-Blenders, Inc., 3801 N. Hawthorne St., Chattanooga, TN 37406NADA 133-833; TYLAN 10 Premix (tylosin phosphate)§ 558.625 (049685).
Southern Micro-Blenders, Inc., 3801 N. Hawthorne St., Chattanooga, TN 37406NADA 135-243; Swine Guard-BN BANMINTH Premix (pyrantel tartrate)§ 558.485 (049685).

In a notice published elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADA 48-647, 96-161, 100-352, 107-002, 119-062, 123-000, 133-833, and 135-243, and all supplements and amendments thereto, is withdrawn, effective March 14, 2011. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these withdrawals of approval.

Following these changes of sponsorship, Yoder Feed, Division of Yoder, Inc., Triple “F”, Inc., NutriBasics Co., Seeco, Inc., and Southern Micro-Blenders, Inc., are no longer the sponsor of an approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for these firms.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, and 558 are amended as follows:

Start Part

PART 510—NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority
[Amended]
Start Amendment Part

2. In § 510.600, in the table in paragraph (c)(1), remove the entries for “Triple “F”, Inc.” and “Yoder Feed, Division of Yoder, Inc.”; and in the table in paragraph (c)(2), remove the entries for “011490”, “011749”, “035369”, “049685”, and “053740”.

End Amendment Part Start Part

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

3. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority Start Amendment Part

4. In § 520.1720a, revise paragraph (b)(6) to read as follows:

End Amendment Part
Phenylbutazone tablets and boluses.
* * * * *

(b) * * *

(6) No. 058829 for use of 100-mg or 1-g tablets in dogs and horses.

* * * * *
Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

End Part Start Amendment Part

5. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority Start Amendment Part

6. In § 558.485, revise the section heading and paragraph (b)(3) to read as follows:

End Amendment Part
Pyrantel.
* * * * *

(b) * * *

(3) Nos. 010439, 012286, 016968, and 017790: 9.6 and 19.2 grams per pound for use as in paragraphs (e)(1)(i) through (e)(1)(iii) of this section.

* * * * *
[Amended]
Start Amendment Part

7. In § 558.625, remove and reserve paragraphs (b)(8), (b)(38), and (b)(80).

End Amendment Part Start Signature

Dated: February 18, 2011.

Bernadette Dunham,

Director, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 2011-4546 Filed 3-1-11; 8:45 am]

BILLING CODE 4160-01-P